Pharmacokinetics of ophthalmic corticosteroids.
作者信息
McGhee C N
机构信息
Tennent Institute of Ophthalmology, Western Infirmary, Glasgow.
出版信息
Br J Ophthalmol. 1992 Nov;76(11):681-4. doi: 10.1136/bjo.76.11.681.
Abstract
摘要
相似文献
1
Pharmacokinetics of ophthalmic corticosteroids.眼科皮质类固醇的药代动力学。
Br J Ophthalmol. 1992 Nov;76(11):681-4. doi: 10.1136/bjo.76.11.681.
2
Penetration of topical and subconjunctival corticosteroids into human aqueous humour and its therapeutic significance.局部及结膜下皮质类固醇药物渗入人房水及其治疗意义。
Br J Ophthalmol. 2009 Jun;93(6):708-13. doi: 10.1136/bjo.2008.154906. Epub 2009 Mar 16.
3
Corticosteroids in the treatment of ocular histoplasmosis.
Int Ophthalmol Clin. 1983 Summer;23(2):111-23. doi: 10.1097/00004397-198302320-00012.
4
Pharmacotherapy: how much drug is there?
Ocul Surf. 2007 Jan;5(1):58-61. doi: 10.1016/s1542-0124(12)70054-x.
5
[Topical drugs absorption in ocular surface diseases].
Arch Soc Esp Oftalmol. 2001 Aug;76(8):457-8.
6
Ocular therapeutics.眼科治疗学
Clin Exp Optom. 2004 Mar;87(2):124-5. doi: 10.1111/j.1444-0938.2004.tb03160.x.
7
Avoiding eye damage from topical corticosteroids.
Drug Ther Bull. 1987 Apr 21;25(8):29-30.
8
[Glucocorticoids in ophthalmology- therapeutic value and strategies of rational utilization].
Oftalmologia. 2001;52(2):47-53.
9
Differentiating intraocular glucocorticoids.鉴别眼内糖皮质激素。
Ophthalmologica. 2010;224 Suppl 1:25-30. doi: 10.1159/000315158. Epub 2010 Aug 18.
10
Ophthalmic use of glucocorticoids.糖皮质激素的眼科应用。
Vet Clin North Am Small Anim Pract. 1982 Feb;12(1):33-9. doi: 10.1016/s0195-5616(82)50003-4.
引用本文的文献
1
Efficacy of the efficacy between dexamethasone versus triamcinolone acetonide after cataract surgery: A systematic review and meta-analysis.白内障手术后地塞米松与曲安奈德疗效比较的疗效：系统评价和荟萃分析。
Medicine (Baltimore). 2024 Jun 7;103(23):e37584. doi: 10.1097/MD.0000000000037584.
2
Topical Treatment for Retinal Degenerative Pathologies: A Systematic Review.局部治疗视网膜退行性病变：系统评价。
Int J Mol Sci. 2023 Apr 28;24(9):8045. doi: 10.3390/ijms24098045.
3
Inhibiting TLR7 Expression in the Retinal Pigment Epithelium Suppresses Experimental Autoimmune Uveitis.抑制视网膜色素上皮细胞中的 TLR7 表达可抑制实验性自身免疫性葡萄膜炎。
Front Immunol. 2022 Jan 5;12:736261. doi: 10.3389/fimmu.2021.736261. eCollection 2021.
4
Effect of Topical Brimonidine 0.15% on Conjunctival Injection after Strabismus Surgery in Children.0.15% 酒石酸溴莫尼定对儿童斜视手术后结膜充血的影响。
J Ophthalmol. 2021 May 4;2021:5574194. doi: 10.1155/2021/5574194. eCollection 2021.
5
The Effect of Perioperative Uveitis Control on the Success of Glaucoma Surgery in Uveitic Glaucoma.围手术期葡萄膜炎控制对葡萄膜炎性青光眼手术成功率的影响
Clin Ophthalmol. 2021 Apr 9;15:1465-1475. doi: 10.2147/OPTH.S301648. eCollection 2021.
6
Dexamethasone Conjugates: Synthetic Approaches and Medical Prospects.地塞米松缀合物：合成方法与医学前景。
Biomedicines. 2021 Mar 27;9(4):341. doi: 10.3390/biomedicines9040341.
7
A Retrospective Data Review Confirms That Topical Preservative-Free Hydrocortisone Improves Inflammation in Dry Eye Disease.一项回顾性数据审查证实，局部用无防腐剂氢化可的松可改善干眼病的炎症。
Clin Ophthalmol. 2020 Oct 30;14:3691-3697. doi: 10.2147/OPTH.S283655. eCollection 2020.
8
Comparison of anti-inflammatory effects of eye drops formulations after uncomplicated cataract surgery.单纯性白内障手术后滴眼液制剂抗炎效果的比较
Ther Adv Ophthalmol. 2020 Sep 21;12:2515841420924304. doi: 10.1177/2515841420924304. eCollection 2020 Jan-Dec.
9
Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives.眼科中的皮质类固醇：药物输送创新、药理学、临床应用和未来展望。
Drug Deliv Transl Res. 2021 Jun;11(3):866-893. doi: 10.1007/s13346-020-00843-z.
10
Corticosteroid eyedrops induced blepharoptosis and atrophy of levator muscle.皮质类固醇眼药水可引起眼睑下垂和提上睑肌萎缩。
Graefes Arch Clin Exp Ophthalmol. 2020 May;258(5):1081-1086. doi: 10.1007/s00417-020-04622-x. Epub 2020 Feb 15.
本文引用的文献
1
Methyl- and fluoro-substituted prednisolones in the blood and aqueous humor of the rabbit. Concentrations.兔血液和房水中甲基和氟取代的泼尼松龙。浓度
Arch Ophthalmol. 1960 Jun;63:943-7. doi: 10.1001/archopht.1960.00950020945008.
2
3
MOVEMENT OF ALBUMIN AND DEXTRAN THROUGH THE SCLERA.白蛋白和右旋糖酐通过巩膜的移动。
Arch Ophthalmol. 1965 Aug;74:248-52. doi: 10.1001/archopht.1965.00970040250024.
4
THE OCULAR UPTAKE OF SUBCONJUNCTIVALLY INJECTED C14 HYDROCORTISONE. 1. TIME AND MAJOR ROUTE OF PENETRATION IN A NORMAL EYE.结膜下注射的C14氢化可的松的眼内摄取。1. 正常眼中的渗透时间和主要途径。
Am J Ophthalmol. 1964 Sep;58:362-6. doi: 10.1016/0002-9394(64)91214-0.
5
Intraocular penetration of local hydrocortisone and cortisone.局部氢化可的松和可的松的眼内渗透
AMA Arch Ophthalmol. 1954 Nov;52(5):769-73. doi: 10.1001/archopht.1954.00920050775013.
6
Effect of particle size on ophthalmic bioavailability of dexamethasone suspensions in rabbits.粒径对兔眼地塞米松混悬液眼用生物利用度的影响。
J Pharm Sci. 1980 Apr;69(4):391-4. doi: 10.1002/jps.2600690407.
7
Prolongation of anti-inflammatory effect of prednisolone acetate. Influence of formulation in high-viscosity gel.
Arch Ophthalmol. 1981 Nov;99(11):2028-9. doi: 10.1001/archopht.1981.03930020904017.
8
Polymorphonuclear leukocyte response. Inhibition following corneal epithelial denudation by steroidal and nonsteroidal anti-inflammatory agents.多形核白细胞反应。甾体类和非甾体类抗炎药对角膜上皮剥脱后的抑制作用。
Arch Ophthalmol. 1981 Jun;99(6):1085-9. doi: 10.1001/archopht.1981.03930011085020.
9
Fluorometholone acetate. A new ophthalmic derivative of fluorometholone.
Arch Ophthalmol. 1982 Apr;100(4):640-1. doi: 10.1001/archopht.1982.01030030642023.
10
Liposomes in topical drug delivery.用于局部给药的脂质体。
Invest Ophthalmol Vis Sci. 1982 Feb;22(2):220-7.
Zotero 插件